Suppliers for CAS
51987-99-6
|
Properties | CAS |
51987-99-6 | Formula |
C8H6N4OS |
|
6 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C8H6N4OS Molecular Weight: 206.22444 Hazard Symbols: Xn WGKGermany: 3
Aea.ltd
P.R.China
Molecular Formula: C8H6N4OS Molecular Weight: 206.22444 Hazard Symbols: Xn WGKGermany: 3
BOC Sciences
USA
Description : TGN 020 is a derivative of thiadiazole and an aquaporin 4 (AQP4) channel blocker (IC50 = 3.1 μM). TGN 020 increases regional cerebral blood flow and reduces ischemia-induced brain edema in mice. - Molecular Weight :206.22
- Melting Point :289-293°C
- Purity :≥99% by HPLC
Molecular Formula : C8H6N4OS Canonical SMILES : C1=CC(=CN=C1)C(=O)NC2=NN=CS2 InChI : InChI=1S/C8H6N4OS/c13-7(6-2-1-3-9-4-6)11-8-12-10-5-14-8/h1-5H,(H,11,12,13) InChIKey : AGEGZHOPKZFKBP-UHFFFAOYSA-N Solubility : In DMSO: 16.67 mg/mL (80.84 mM; Need ultrasonic) Appearance : White to Off-White Solid Storage : Powder, -20°C, 3 years; 4°C, 2 years; In solvent, -80°C, 6 months; -20°C, 1 month Synonyms : TGN-020; TGN 020; TGN020; N-1,3,4-Thiadiazol-2-yl-3-pyridinecarboxamide; 2-(Nicotinamido)-1,3,4-thiadiazole
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : TGN 020 is a derivative of thiadiazole and an aquaporin 4 (AQP4) channel blocker (IC50 = 3.1 μM). TGN 020 increases regional cerebral blood flow and reduces ischemia-induced brain edema in mice. - Molecular Weight :206.22
- Melting Point :289-293°C
- Purity :≥99% by HPLC
Molecular Formula : C8H6N4OS Canonical SMILES : C1=CC(=CN=C1)C(=O)NC2=NN=CS2 InChI : InChI=1S/C8H6N4OS/c13-7(6-2-1-3-9-4-6)11-8-12-10-5-14-8/h1-5H,(H,11,12,13) InChIKey : AGEGZHOPKZFKBP-UHFFFAOYSA-N Solubility : In DMSO: 16.67 mg/mL (80.84 mM; Need ultrasonic) Appearance : White to Off-White Solid Storage : Powder, -20°C, 3 years; 4°C, 2 years; In solvent, -80°C, 6 months; -20°C, 1 month Synonyms : TGN-020; TGN 020; TGN020; N-1,3,4-Thiadiazol-2-yl-3-pyridinecarboxamide; 2-(Nicotinamido)-1,3,4-thiadiazole
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : TGN 020 is a derivative of thiadiazole and an aquaporin 4 (AQP4) channel blocker (IC50 = 3.1 μM). TGN 020 increases regional cerebral blood flow and reduces ischemia-induced brain edema in mice. - Molecular Weight :206.22
- Melting Point :289-293°C
- Purity :≥99% by HPLC
Molecular Formula : C8H6N4OS Canonical SMILES : C1=CC(=CN=C1)C(=O)NC2=NN=CS2 InChI : InChI=1S/C8H6N4OS/c13-7(6-2-1-3-9-4-6)11-8-12-10-5-14-8/h1-5H,(H,11,12,13) InChIKey : AGEGZHOPKZFKBP-UHFFFAOYSA-N Solubility : In DMSO: 16.67 mg/mL (80.84 mM; Need ultrasonic) Appearance : White to Off-White Solid Storage : Powder, -20°C, 3 years; 4°C, 2 years; In solvent, -80°C, 6 months; -20°C, 1 month Synonyms : TGN-020; TGN 020; TGN020; N-1,3,4-Thiadiazol-2-yl-3-pyridinecarboxamide; 2-(Nicotinamido)-1,3,4-thiadiazole
More details are to be found here
|